2005-04-01
Preconception care. Teratogenic risks of medication
Publication
Publication
More than 40% of women take medication during the first trimester of pregnancy. One of the principal goals of preconception care is the primary prevention of drug-induced teratogenic exposure. This is defined as one that may produce a permanent abnormality of structure or function in an organism exposed during embryonic or foetal life. Paternal risk factors should be evaluated as well.
| Additional Metadata | |
|---|---|
| , , , | |
| doi.org/10.1016/j.ics.2005.02.041, hdl.handle.net/1765/54702 | |
| Organisation | Department of Gynaecology & Obstetrics |
|
Steegers, E. (2005). Preconception care. Teratogenic risks of medication. doi:10.1016/j.ics.2005.02.041 |
|